All Work

Jon C. Ogg

Uptick in Financial Security For Americans

Bankrate.com has issued its Financial Security Index for January, showing that the reading posted a gain for the second straight month. The gain is monthly, but this is a lower security reading from one…

Jon C. Ogg · 15 years ago

J&J… When Beating Earnings Hits A Headwind (JNJ)

Johnson & Johnson (NYSE: JNJ) managed to marginally beat earnings expectations this Tuesday morning.  This is the first of the consumer products and medical products companies to report, so this one could have a…

Jon C. Ogg · 15 years ago

Cramer Now Touts Merck For Drug & Yield (MRK, PFE)

Jim Cramer has touted several DJIA upside calls in 2012, but on Monday’s MAD MONEY on CNBC Cramer touted Merck & Company, Inc. (NYSE: MRK) as the great pharma outfit with what may be the…

Jon C. Ogg · 15 years ago

TI Earnings Confusion Over Charges (TXN)

Texas Instruments Inc. (NYSE: TXN) is out with its earnings for the fourth quarter.  The chip giant reported earnings of $0.25 EPS on $3.42 billion in revenues in what feels a bit confusing for…

Jon C. Ogg · 15 years ago

Why the Cost Plus Analyst Upgrade Matters (CPWM, PIR)

Cost Plus, Inc. (NASDAQ: CPWM) is much less trafficked as a stock compared to its store.  From having great internationally made and designed furniture deals to great international selections in food, wine, and beer,…

Jon C. Ogg · 15 years ago

Panera Overvalued (PNRA)

Panera Bread Company (NASDAQ: PNRA) reached a share price where you just know that analysts had to either start lifting their price targets or would have to make downgrades based upon valuation.  Shares closed Friday…

Jon C. Ogg · 15 years ago

Analysts Not Speaking Jive (JIVE)

Jive Software, Inc. (NASDAQ: JIVE) is seeing some soft trading on the day that its quiet period has ended after its initial public offering.  This company was supposed to be a winner from its…

Jon C. Ogg · 15 years ago

New CEO For Top RIM Job Already Under Scrutiny (RIMM)

Research In Motion Limited (NASDAQ: RIMM) was supposed to win the moment is announced a change in the company’s top adult supervision.  It should have been taken as very good news that co-CEOs Jim…

Jon C. Ogg · 15 years ago

Blockbuster Opportunity for Galena Biopharma? GALE)

Galena Biopharma, Inc. (NASDAQ: GALE) is unknown to most investors out there.  The company recently had news about the initiation of its Phase III PRESENT trial for NeuVax (E75 peptide plus GM-CSF) vaccine in…

Jon C. Ogg · 15 years ago

Wells Fargo Sticks By Solar Financing (WFC, XEL)

Wells Fargo & Company (NYSE: WFC) has stood by the equity financing for a 53.5 megawatt (MW) multi-site solar project in New Mexico.  The 53.5MW solar project is called one of the largest photovoltaic solar…

Jon C. Ogg · 15 years ago